Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years.
McClung MR; Balske A; Burgio DE; Wenderoth D; Recker RR; Osteoporosis International: A Journal Established As Result Of Cooperation Between The European Foundation For Osteoporosis And The National Osteoporosis Foundation Of The USA, 2013, vol. 24, issue 1, p 301, ISSN 14332965. ISBN 14332965.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef